PDE5A and Alzheimer disease: The study showed that PDE-5 inhibitors were not associated with ADRD risk in observational analysis and sildenafil did not ameliorate abnormalities relevant to Alzheimer’s disease in most cell culture–based phenotypic assays although did appear to have slight anti-inflammatory effects.